Founded in
2009
Number of Employees Nationwide
4,807
Data as of September 30, 2026
SMO Project Experience at Home and Abroad
4,900+
Data as of September 30, 2026
Stock Code
301257.SZ
Innovative Clinical Trial Solutions
Accelerating New Medicines for Patients
ClinPlus’ self-developed big-data modeling system leverages performance data from historical projects to generate site selection, site initiation, patient recruitment, risk, quality, data, patient & investigator cost and other models, delivering precise execution strategies for clinical trials.
To date, ClinPlus modeling data has been validated by over 400 SSU projects and 600+ patient recruitment projects. The matching rates against project plans reach 97.89% and 94.38% respectively. It cuts the strategy development cycle for clinical trial execution from months to just one week.
ClinPlus SSU team covers key regions nationwide, with in-depth knowledge of site workflows. We develop contingency plans to proactively mitigate potential obstacles and risks during site initiation.
After the initiation plan is finalized, ClinPlus SSU Services leverages our innovative site initiation platform to deliver in-depth interpretation of site requirements and clinical trial protocol analysis. The system enables one-click generation of multi-site essential documents, eliminating manual documentation errors and reducing time costs.
ClinPlus delivers customized, professional, flexible and sustainable FSP services for clients.
Dual internal & external candidate sourcing channels; comprehensive training system; full-lifecycle workforce management by dedicated HR teams to boost productivity; diverse career development opportunities for staff.
Backed by a decade of professional experience focusing on SMO services, ClinPlus has established stable long-term FSP partnerships with numerous renowned research sites and sponsors, with some relationships spanning more than 10 years.
ClinPlus quality control team is deployed in core cities nationwide, professionally delivering research site audits, trial document audits, CAPA follow-up until closure, consultation and training services. We ensure all clinical trial procedures comply with GCP, clinical trial protocols, relevant SOPs and applicable laws & regulations.
We supervise project execution, identify and rectify issues in a timely manner, protect the rights and interests of trial subjects, guarantee scientific, authentic and reliable clinical trial data, and ensure standardized operations.
Honors & Qualifications
Honors & Qualifications
Top 10 Most Influential CRO Enterprises “2023 China Biomedical Industry Value List”
Excellent Case for High-Quality Development of the Big Health Industry
Awarded by Economic Information Daily
Shanghai High-tech Enterprise Certificate
Recognized as "Shanghai High-tech Enterprise" in 2024 and awarded the Shanghai High-tech Enterprise Certificate.
Top 100 Most Popular Listed Companies
Tonghuashun Annual Selection of Listed Companies
Future Pioneer Industry Award
Awarded by Huangpu District People's Government of Shanghai
Annual Technology Leap Award
Awarded by Dapuqiao Sub-district, Huangpu District, Shanghai
Participated in drafting and compiling Specification for Management and Competency Assessment of Clinical Research Coordinators (Shanghai)
Huangpu District Enterprise Technology Center
Jointly awarded by Huangpu District Commerce Commission, Huangpu District Science and Technology Commission and Huangpu District Finance Bureau of Shanghai
Shanghai Specialized, Refined, Differential and Innovative Enterprise
Awarded by Shanghai Municipal Commission of Economy and Informatization
Huangpu District Private Enterprise Headquarters of Shanghai
Member Unit of Federation of Modern Service Industries
Zhangjiang Star
Zhaopin 2023 Preferred Employer
2024 Top 100 Happy Enterprises
Top 30 Excellent Employers
Jointly awarded by The Economic Observer and FESCO
China Innovative Drug Decade Honor List – "Industry-leading CRO Company" Award
China Securities Journal – Listed Company Golden Bull Award · Golden Information Disclosure Award
Global Times – Demonstration Case of Industrial Practice for New-quality Productivity
2025 Shanghai Specialized, Refined, Differential & Innovative Enterprises – Top 50+ Most Growth-oriented Brand Value
2026 Securities Star ESG New Benchmark Enterprise Award
Excellent Governance – "Innovation Award", by Securities Star